Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLBR
2301
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $1.74M | ﹤0.01% |
162,230
+87,100
| +116% | +$1.06M |
|
2302
Azenta
AZTA
$1.46B
| $1.74M | ﹤0.01% |
167,200
-148,257
| -47% | -$1.42M |
|
|
CHCT
2303
Community Healthcare Trust
CHCT
$432M
| $1.74M | ﹤0.01% |
94,000
+42,470
| +82% | +$769K |
|
|
FDML
2304
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $1.74M | ﹤0.01% |
175,730
+35,500
| +25% | +$222K |
|
2305
Meritage Homes
MTH
$4.76B
| $1.74M | ﹤0.01% |
+95,200
| New | +$1.52M |
|
2306
Alliant Energy
LNT
$18.3B
| $1.73M | ﹤0.01% |
46,600
+33,200
| +248% | +$1.12M |
|
|
AMNB
2307
DELISTED
American National Bankshares Inc
AMNB
| $1.73M | ﹤0.01% |
68,300
+7,630
| +13% | +$188K |
|
|
RTK
2308
DELISTED
Rentech, Inc.
RTK
| $1.73M | ﹤0.01% |
778,674
+336,394
| +76% | +$728K |
|
|
TAL
2309
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
| $1.73M | ﹤0.01% |
111,806
+64,706
| +137% | +$777K |
|
|
CSCI
2310
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $1.72M | ﹤0.01% |
5,168
+290
| +6% | +$95.6K |
|
|
ENH
2311
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $1.71M | ﹤0.01% |
+26,195
| New | +$1.64M |
|
|
IMI
2312
DELISTED
Intermolecular, Inc.
IMI
| $1.71M | ﹤0.01% |
676,000
+74,900
| +12% | +$169K |
|
|
UFS
2313
DELISTED
DOMTAR CORPORATION (New)
UFS
| $1.71M | ﹤0.01% |
42,200
-38,042
| -47% | -$1.3M |
|
2314
E.W. Scripps
SSP
$320M
| $1.7M | ﹤0.01% |
+109,283
| New | +$1.92M |
|
|
CXP
2315
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $1.7M | ﹤0.01% |
+77,200
| New | +$1.67M |
|
|
SA
2316
Seabridge Gold
SA
$3.61B
| $1.7M | ﹤0.01% |
154,800
+59,560
| +63% | +$520K |
|
2317
ICL Group
ICL
$7.16B
| $1.69M | ﹤0.01% |
394,700
+117,600
| +42% | +$485K |
|
2318
Astec Industries
ASTE
$997M
| $1.69M | ﹤0.01% |
+36,245
| New | +$1.45M |
|
2319
CarParts.com
PRTS
$47.1M
| $1.69M | ﹤0.01% |
65,950
+3,860
| +6% | +$107K |
|
2320
Harvard Bioscience
HBIO
$30.3M
| $1.68M | ﹤0.01% |
55,750
-930
| -2% | -$26.4K |
|
|
XRM
2321
DELISTED
Xerium Technologies Inc (new)
XRM
| $1.68M | ﹤0.01% |
322,500
+11,700
| +4% | +$95.2K |
|
2322
RCI Hospitality Holdings
RICK
$236M
| $1.68M | ﹤0.01% |
189,800
-12,100
| -6% | -$106K |
|
2323
Arbor Realty Trust
ABR
$950M
| $1.68M | ﹤0.01% |
248,300
+39,600
| +19% | +$260K |
|
2324
Lifetime Brands
LCUT
$226M
| $1.68M | ﹤0.01% |
111,500
+16,800
| +18% | +$207K |
|
|
SNT
2325
Senstar Technologies
SNT
$42.9M
| $1.68M | ﹤0.01% |
338,000
+17,200
| +5% | +$74.7K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.